Five stakeholders join voices calling for faster and more equitable access to genetic testing in breast cancer
For Amber, as a mother with stage 4 breast cancer, her concern is for her family. Amber wants those she loves to be able to access genetic testing. Her hope is with this knowledge, perhaps they avoid the same future she faces.
“It’s so important we get other people tested, because knowledge is power” – Amber, Breast Cancer Patient
Etched in Krystal’s mind are the dates each of the women in her life received their cancer diagnosis—from great grandmother through to her own mother. Empowered with genetic testing, Krystal has embarked upon key preventative actions to break that cycle, and she remains cancer free.
“Pathology technology was the unsung hero in my experience… creating a pathway to prevention” – Krystal Barter, Patient Advocate
We know genomic-led care for breast cancer is relevant at every step. From assessing inherited risk to defining treatment and other care decisions, so why do we still have inequities in access and chronic delays in funding for testing?
“Pathology technology is advancing at a rapid rate, and it’s really important that we’re able to keep up” – Vicki Durston, BCNA
The chorus of voices throughout the community and healthcare professionals are united in their call.
“It is an exciting time, but it does lead to challenges in terms of accessing molecular testing in a timely manner, as well as in a widespread fashion throughout Australia” – Prof Elgene Lim, Breast Cancer Trials
Watch this powerful video capturing this message from five representatives across the spectrum of stakeholders all fighting against breast cancer.
Visit The Missing Piece website to learn more.
If we want to hold up our healthcare responses as world-class, we can’t afford to be delaying access to funded genetic testing.